MX2019010837A - Conjugado biodegradable de farmaco-polimero. - Google Patents
Conjugado biodegradable de farmaco-polimero.Info
- Publication number
- MX2019010837A MX2019010837A MX2019010837A MX2019010837A MX2019010837A MX 2019010837 A MX2019010837 A MX 2019010837A MX 2019010837 A MX2019010837 A MX 2019010837A MX 2019010837 A MX2019010837 A MX 2019010837A MX 2019010837 A MX2019010837 A MX 2019010837A
- Authority
- MX
- Mexico
- Prior art keywords
- functional group
- formula
- group
- terminal functional
- instance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/595—Polyamides, e.g. nylon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/08—Polyhydrazides; Polytriazoles; Polyaminotriazoles; Polyoxadiazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/458,546 US10113033B2 (en) | 2013-03-08 | 2017-03-14 | Polymer conjugate for delivery of a bioactive agent |
| AU2017900888A AU2017900888A0 (en) | 2017-03-14 | Biodegradable drug-polymer conjugate | |
| PCT/AU2018/050234 WO2018165711A1 (en) | 2017-03-14 | 2018-03-14 | Biodegradable drug-polymer conjugate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019010837A true MX2019010837A (es) | 2019-12-19 |
Family
ID=63521659
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019010837A MX2019010837A (es) | 2017-03-14 | 2018-03-14 | Conjugado biodegradable de farmaco-polimero. |
| MX2019010904A MX2019010904A (es) | 2017-03-14 | 2018-03-14 | Conjugado de farmaco-polimero. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019010904A MX2019010904A (es) | 2017-03-14 | 2018-03-14 | Conjugado de farmaco-polimero. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11787906B2 (https=) |
| EP (2) | EP3595670A4 (https=) |
| JP (2) | JP7355649B2 (https=) |
| KR (2) | KR102642432B1 (https=) |
| CN (4) | CN110461336A (https=) |
| AU (2) | AU2018233158B2 (https=) |
| CA (1) | CA3054084A1 (https=) |
| CL (1) | CL2019002600A1 (https=) |
| IL (2) | IL269321B (https=) |
| MX (2) | MX2019010837A (https=) |
| NZ (2) | NZ756626A (https=) |
| SG (2) | SG11201907956UA (https=) |
| WO (2) | WO2018165710A1 (https=) |
| ZA (2) | ZA201905589B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11696955B2 (en) | 2017-03-14 | 2023-07-11 | Polyactiva Pty Ltd | Drug-polymer conjugate |
| MX2019010837A (es) * | 2017-03-14 | 2019-12-19 | Polyactiva Pty Ltd | Conjugado biodegradable de farmaco-polimero. |
| WO2021024041A1 (en) | 2019-08-07 | 2021-02-11 | Ripple Therapeutics Corporation | Controlled release drug dimers |
| CA3154867A1 (en) * | 2019-09-19 | 2021-03-25 | Polyactiva Pty Ltd | Biodegradable drug-polymer conjugate |
| MX2022013665A (es) | 2020-05-01 | 2022-11-30 | Ripple Therapeutics Corp | Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares. |
| WO2024084056A1 (en) * | 2022-10-21 | 2024-04-25 | Etherna Immunotherapies Nv | Ionizable lipids |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1044797B (it) | 1974-10-15 | 1980-04-21 | Ferruti Paolo | Alti polimeri contenenti radicali prostaglandinici processo per la loro preparazione e loro impiego |
| JPH03220201A (ja) | 1988-11-18 | 1991-09-27 | Eisai Co Ltd | プロスタグランジン類と多糖類の結合体 |
| JP4419368B2 (ja) | 2002-07-25 | 2010-02-24 | 小野薬品工業株式会社 | プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤 |
| CA2617907A1 (en) | 2005-08-05 | 2007-02-15 | Syntarga B.V. | Triazole-containing releasable linkers and conjugates comprising the same |
| MY155629A (en) | 2008-10-10 | 2015-11-13 | Polyactiva Pty Ltd | Biodegradable polymer-bioactive moiety conjugates |
| SI2340271T1 (sl) | 2008-10-10 | 2019-08-30 | Polyactiva Pty Ltd. | Konjugati polimer-bioaktivnega sredstva |
| US8535655B2 (en) * | 2008-10-10 | 2013-09-17 | Polyactiva Pty Ltd. | Biodegradable polymer—bioactive moiety conjugates |
| US20100104654A1 (en) | 2008-10-27 | 2010-04-29 | Allergan, Inc. | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| US20120130045A1 (en) | 2009-06-01 | 2012-05-24 | Ablitech, Inc. | Biomolecule-polymer conjugates and methods of making same |
| FR2961694B1 (fr) | 2010-06-29 | 2013-01-25 | Thea Lab | Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur |
| WO2012075117A2 (en) | 2010-12-01 | 2012-06-07 | Ablitech, Inc. | Small molecule-polymer conjugates and methods of making same |
| WO2012139164A1 (en) * | 2011-04-12 | 2012-10-18 | Polyactiva Pty Ltd | Polymer conjugated prostaglandin analogues |
| JP2013035802A (ja) | 2011-08-10 | 2013-02-21 | D Western Therapeutics Institute Inc | 緑内障又は高眼圧症の予防又は治療剤 |
| MY190370A (en) * | 2012-06-26 | 2022-04-18 | Polyactiva Pty Ltd | Polymer-nsaid conjugate |
| US10113033B2 (en) | 2013-03-08 | 2018-10-30 | Polyactiva Pty Ltd | Polymer conjugate for delivery of a bioactive agent |
| DK2964224T3 (en) * | 2013-03-08 | 2024-10-14 | Polyactiva Pty Ltd | Polymer conjugate for delivery of a bioactive agent |
| MX2019010837A (es) * | 2017-03-14 | 2019-12-19 | Polyactiva Pty Ltd | Conjugado biodegradable de farmaco-polimero. |
| US11696955B2 (en) | 2017-03-14 | 2023-07-11 | Polyactiva Pty Ltd | Drug-polymer conjugate |
| US11207417B2 (en) | 2017-03-14 | 2021-12-28 | Polyactiva Pty Ltd | Drug-polymer conjugate |
-
2018
- 2018-03-14 MX MX2019010837A patent/MX2019010837A/es unknown
- 2018-03-14 AU AU2018233158A patent/AU2018233158B2/en active Active
- 2018-03-14 EP EP18767240.7A patent/EP3595670A4/en active Pending
- 2018-03-14 JP JP2019551318A patent/JP7355649B2/ja active Active
- 2018-03-14 IL IL269321A patent/IL269321B/en unknown
- 2018-03-14 AU AU2018233159A patent/AU2018233159C1/en active Active
- 2018-03-14 US US16/493,252 patent/US11787906B2/en active Active
- 2018-03-14 SG SG11201907956UA patent/SG11201907956UA/en unknown
- 2018-03-14 SG SG11201907931WA patent/SG11201907931WA/en unknown
- 2018-03-14 EP EP18768053.3A patent/EP3595728A4/en active Pending
- 2018-03-14 JP JP2019551307A patent/JP7204661B2/ja active Active
- 2018-03-14 KR KR1020197027318A patent/KR102642432B1/ko active Active
- 2018-03-14 CN CN201880017971.3A patent/CN110461336A/zh active Pending
- 2018-03-14 NZ NZ756626A patent/NZ756626A/en unknown
- 2018-03-14 MX MX2019010904A patent/MX2019010904A/es unknown
- 2018-03-14 KR KR1020197029230A patent/KR102642433B1/ko active Active
- 2018-03-14 CN CN202511024390.0A patent/CN120919336A/zh active Pending
- 2018-03-14 WO PCT/AU2018/050233 patent/WO2018165710A1/en not_active Ceased
- 2018-03-14 WO PCT/AU2018/050234 patent/WO2018165711A1/en not_active Ceased
- 2018-03-14 IL IL269323A patent/IL269323B/en unknown
- 2018-03-14 CN CN201880029815.9A patent/CN110662561A/zh active Pending
- 2018-03-14 CN CN202511030510.8A patent/CN120919337A/zh active Pending
- 2018-03-14 NZ NZ757356A patent/NZ757356A/en unknown
- 2018-03-14 CA CA3054084A patent/CA3054084A1/en active Pending
-
2019
- 2019-08-23 ZA ZA2019/05589A patent/ZA201905589B/en unknown
- 2019-09-12 CL CL2019002600A patent/CL2019002600A1/es unknown
- 2019-09-17 ZA ZA2019/06133A patent/ZA201906133B/en unknown
-
2023
- 2023-07-26 US US18/226,713 patent/US12503553B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019010837A (es) | Conjugado biodegradable de farmaco-polimero. | |
| MX2015001509A (es) | Poliesteres. | |
| RU2007115075A (ru) | Новый блок-сополимер, мицеллярный препарат и противораковое средство, включающее мицеллярный препарат в качестве активного ингредиента | |
| CO6220850A2 (es) | Mezclas de fertilizante-polimero que inhiben la nitrificacion en los suelos | |
| PE20141219A1 (es) | Profarmaco de adrenomedulina basado en polietilenglicol y su uso | |
| TW200626691A (en) | Acrylic pressure-sensitive adhesive composition with good re-workability, adhesive sheet, and method of preparing the sheet | |
| MX391071B (es) | Conjugados de un resto de il-7 y un polímero. | |
| EA201000747A1 (ru) | Система и способ трансдермальной доставки и способ получения системы трансдермальной доставки | |
| RU2012144848A (ru) | Быстро растворяющиеся системы, освобождающие лекарственные препараты | |
| AR060295A1 (es) | Uso de surfactantes sililados organomodificados resistentes a la hidrolisis | |
| MX377120B (es) | Composicion curable fotocromatica, producto curado de la misma y laminado que incluye el producto curado. | |
| ATE518896T1 (de) | Kammpolymere enthaltende wirkstoffformulierungen | |
| WO2008124735A3 (en) | Multi-functional polyglutamate drug carriers | |
| MX2009005623A (es) | Copolimeros de cepillo. | |
| MX351429B (es) | Materiales dentales basados en monómeros con propiedades de despegado según sea necesario. | |
| MX2022001161A (es) | Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmaceuticas que los contienen y sus usos como agentes proapoptoticos. | |
| MX2016010140A (es) | Nuevos eteres de celulosa esterificados de alto peso molecular y homogeneidad. | |
| PE20171510A1 (es) | Copolimeros de polidialilamina reticulados para el tratamiento de la diabetes de tipo 2 | |
| AR093299A1 (es) | Adyuvantes adherentes de poliamida y poliimida | |
| AR109686A1 (es) | Selladoras de esfera degradables con características de solubilidad | |
| BR112018004260A2 (pt) | composição polimerizável, polimerizado e artigo óptico | |
| CL2023000460A1 (es) | Envase soluble en agua que contiene colorante y procedimiento para preparar solución acuosa coloreada | |
| WO2013054298A3 (en) | Modified polyethylene glycols and their supramolecular complexes with biologically active macromolecules | |
| AR065930A1 (es) | Conjugado wortmannina-rapalogo y sus usos | |
| CO2021002726A2 (es) | Copolímeros de óxido de dimetilsiloxano-alquileno |